These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 31577094)

  • 1. Rosuvastatin reduces expression of tissue factor through inhibiting RhoA/ROCK pathway to ameliorate atherosclerosis.
    Zhou J; Yin G; Yu T; Zhang Y; Tian X; Xia D; Shi L
    Panminerva Med; 2021 Sep; 63(3):402-403. PubMed ID: 31577094
    [No Abstract]   [Full Text] [Related]  

  • 2. Targeting of RhoA/ROCK signaling ameliorates progression of diabetic nephropathy independent of glucose control.
    Kolavennu V; Zeng L; Peng H; Wang Y; Danesh FR
    Diabetes; 2008 Mar; 57(3):714-23. PubMed ID: 18083785
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of ERM-family proteins via RhoA-ROCK signaling increases intestinal P-gp expression and leads to attenuation of oral morphine analgesia.
    Kobori T; Harada S; Nakamoto K; Tokuyama S
    J Pharm Sci; 2013 Mar; 102(3):1095-105. PubMed ID: 23303573
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 3-Hydroxymethyl coenzyme A reductase inhibition attenuates spontaneous smooth muscle tone via RhoA/ROCK pathway regulated by RhoA prenylation.
    Rattan S
    Am J Physiol Gastrointest Liver Physiol; 2010 Jun; 298(6):G962-9. PubMed ID: 20378830
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of rosuvastatin versus atorvastatin on rho-associated coiled-coil containing protein kinase activity and endothelial function in patients with atherosclerosis.
    Liu B; Cao HM; Li GY; Liu M; Feng J; Li J; Wang Q
    J Int Med Res; 2011; 39(6):2314-22. PubMed ID: 22289549
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Simvastatin Increases Fibulin-2 Expression in Human Coronary Artery Smooth Muscle Cells via RhoA/Rho-Kinase Signaling Pathway Inhibition.
    Serra N; Rosales R; Masana L; Vallvé JC
    PLoS One; 2015; 10(7):e0133875. PubMed ID: 26207907
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RhoA/Rho kinase pathway contributes to the pathogenesis of thermal hyperalgesia in diabetic mice.
    Ohsawa M; Aasato M; Hayashi SS; Kamei J
    Pain; 2011 Jan; 152(1):114-122. PubMed ID: 20980102
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of the RhoA/Rho-associated, coiled-coil-containing protein kinase-1 pathway is involved in the therapeutic effects of simvastatin on pulmonary arterial hypertension.
    Liu WH; Xu XH; Luo Q; Zhang HL; Wang Y; Xi QY; Zhao ZH; Liu ZH
    Clin Exp Hypertens; 2018; 40(3):224-230. PubMed ID: 29319354
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathophysiological effects of RhoA and Rho-associated kinase on cardiovascular system.
    Cai A; Li L; Zhou Y
    J Hypertens; 2016 Jan; 34(1):3-10. PubMed ID: 26556565
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The interplay of signaling pathway in endothelial cells-matrix stiffness dependency with targeted-therapeutic drugs.
    Vania V; Wang L; Tjakra M; Zhang T; Qiu J; Tan Y; Wang G
    Biochim Biophys Acta Mol Basis Dis; 2020 May; 1866(5):165645. PubMed ID: 31866415
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting RhoA/ROCK pathway in pulmonary arterial hypertension.
    Antoniu SA
    Expert Opin Ther Targets; 2012 Apr; 16(4):355-63. PubMed ID: 22449260
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involvement of PtdIns(4,5)P2 in the regulatory mechanism of small intestinal P-glycoprotein expression.
    Kobori T; Harada S; Nakamoto K; Tokuyama S
    J Pharm Sci; 2014 Feb; 103(2):743-51. PubMed ID: 24311454
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of mycophenolate mofetil on chronic allograft nephropathy by affecting RHO/ROCK signal pathways.
    Song J; Lu YP; Luo GH; Yang L; Ma X; Xia QJ; Shi YJ; Li YP
    Transplant Proc; 2008 Oct; 40(8):2790-4. PubMed ID: 18929863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atorvastatin but not elocalcitol increases sildenafil responsiveness in spontaneously hypertensive rats by regulating the RhoA/ROCK pathway.
    Fibbi B; Morelli A; Marini M; Zhang XH; Mancina R; Vignozzi L; Filippi S; Chavalmane A; Silvestrini E; Colli E; Adorini L; Vannelli GB; Maggi M
    J Androl; 2008; 29(1):70-84. PubMed ID: 17699803
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of RhoA promotes the proliferation and migration of cervical cancer cells.
    Liu X; Chen D; Liu G
    Biosci Biotechnol Biochem; 2014; 78(11):1895-901. PubMed ID: 25104222
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Correlation between expression of RhoA and Rho kinase in uterine smooth muscle and the onset of labor].
    Gao J; Ding YL
    Zhonghua Fu Chan Ke Za Zhi; 2009 May; 44(5):345-9. PubMed ID: 19573309
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors interfere with angiogenesis by inhibiting the geranylgeranylation of RhoA.
    Park HJ; Kong D; Iruela-Arispe L; Begley U; Tang D; Galper JB
    Circ Res; 2002 Jul; 91(2):143-50. PubMed ID: 12142347
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vincristine promotes migration and invasion of colorectal cancer HCT116 cells through RhoA/ROCK/ Myosin light chain pathway.
    Jin X; Liu K; Jiao B; Wang X; Huang S; Ren W; Zhao K
    Cell Mol Biol (Noisy-le-grand); 2016 Oct; 62(12):91-96. PubMed ID: 27894406
    [TBL] [Abstract][Full Text] [Related]  

  • 19. α-TEA inhibits the growth and motility of human colon cancer cells via targeting RhoA/ROCK signaling.
    Yao J; Gao P; Xu Y; Li Z
    Mol Med Rep; 2016 Sep; 14(3):2534-40. PubMed ID: 27432222
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic potential of RhoA/Rho kinase inhibitors in pulmonary hypertension.
    Oka M; Fagan KA; Jones PL; McMurtry IF
    Br J Pharmacol; 2008 Oct; 155(4):444-54. PubMed ID: 18536743
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.